XML 30 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Event
9 Months Ended
Sep. 30, 2018
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
13.
Subsequent Event
 
In October 2018, the Company entered into an agreement with a biopharmaceutical company and a cancer research center to conduct a clinical research study. The Company is obligated to make a payment upon execution of the agreement for approximately $32,000 and future obligations of approximately $150,000 upon certain milestones being met.